Clinicopathological correlates in frontotemporal dementia

Annals of Neurology

Volumn 56, Issue 3, 2004, Pages 399-406

  Hodges, John R ^a,b,c   Davies, R Rhys ^b   Xuereb, John H ^b   Casey, Barney ^d   Broe, Melissa ^d   Bak, Thomas H ^b   Kril, Jillian J ^d   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; AGED; AMNESIA; APHASIA; APRAXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; FEMALE; FRONTOTEMPORAL DEMENTIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOTOR NEURON DISEASE; MULTICENTER STUDY; PARKINSONISM; PRIORITY JOURNAL; SEMANTICS; SYMPTOMATOLOGY; SYNDROME DELINEATION;

AGED; AGED, 80 AND OVER; BRAIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TAU PROTEINS;

EID: 4444248435     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20203     Document Type: Article

References (45)

1. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58:1615-1621.
2. Goedert M, Crowther RA, Spillantini MG. Tau mutations cause frontotemporal dementias. Neuron 1998;21:955-958.
3. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608-1614.
4. Raskovsky K, Salmon DP, Ho GJ, et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 2002;58:1801-1808.
5. Dickson DW. Pick's disease: a modern approach. Brain Pathol 1998;8:339-354.
6. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1998;91:127-134.
7. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809.
8. Hodges JR, Davies R, Xuereb J, et al. Survival in frontotemporal dementia. Neurology 2003;61:349-354.
9. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
10. Hodges JR, Miller BL. The classification, genetics and neuropathology of frontotemporal dementia (FTD). Introduction to the special topic papers: part I. Neurocase 2001;7:31-35.
11. Bozeat S, Gregory CA, Lambon Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2000;69:178-186.
12. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115:1783-1806.
13. Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form of circumscribed cerebral atrophy. Behav Neurol 1989;2: 167-182.
14. Nestor PJ, Graham NL, Fryer TD, et al. Progressive non-fluent aphasia is associated with hypometabolism centered on the left anterior insula. Brain 2003;126:2406-2418.
15. Grossman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc 2002;8:566-583.
16. Bak T, Hodges JR. Motor neurone disease, dementia and aphasia coincidence, co-occurrence or continuum? J Neurol 2001; 248:260-270.
17. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368-1375.
18. Broe M, Hodges JR, Schofield E, et al. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003;60:1005-1011.
19. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2.
20. McKeith IG, Galasko D, Kosaka K, et al. Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on Dementia with Lewy Bodies (CDLB) international Workgtoup. Neurology 1996;47:1113-1124.
21. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):6-15.
22. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57: 129-133.
23. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-374.
24. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
25. Bathgate D, Snowden JS, Varma A, et al. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001;103:367-378.
26. Okamoto K, Hirai S, Yamazaki T, et al. New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 1991;129: 233-236.
27. Yaguchi M, Okamoto K, Nakazato Y. Frontotemporal dementia with cerebral intraneuronal ubiquitin-positive inclusions but lacking lower motor neuron involvement. Acta Neuropathol 2003;105:81-85.
28. Mackenzie IRA, Feldman H. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol 2003;105:98-102.
29. Rossor MN, Revesz T, Lantos PL, Warrington EK. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 2000;123:267-276.
30. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
31. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain 1994;117: 1183-1196.
32. Boeve BF, Maraganore DM, Parisi JE, et al. Pathological heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;54:795-800.
33. Tsuchiya K, Mitani K, Arai T, et al. Argyrophilic grain disease mimicking temporal Pick's disease: a clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years, Acta Neutopathol 2001;102:195-199.
34. Togo T, Cookson N, Dickson DW. Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 2002;12:45-52.
35. Jellinger KA. Dementia with grains (argyrophilic grain disease). Brain Pathol 1998;8:377-386.
36. Togo T, Sahara N, Yen S-H, et al. Agyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002; 61:547-556.
37. Maurage C-A, Sergeant N, Schraen-Maschke S, et al. A diffuse form of agyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathol 2003;106:575-583.
38. Braak H, Braak E. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transmission 1998;105:801-819.
39. Graham NL, Patterson K, Bak T, Hodges JR. Language function and dysfunction in corticobasal degeneration. Neurology 2003;61:493-499.
40. Kertesz A, Munoz DG. Pick's disease and Pick complex. New York: Wiley-Liss, 1998.
41. Snowden JS, Neary D, Mann D. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. New York: Churchill Livingstone, 1996.
42. Mesulam MM. Primary progressive aphasia. Ann Neurol 2001; 49:425-432.
43. Hayashi S, Toyoshima Y, Hasegawa M, et al, Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 2002;51:525-530.
44. Tsuchiya K, Ikeda M, Hasegawa K, et al. Distribution of cerebral cortical lesions in Pick's disease with Pick bodies: a clinicopathological study of six autopsy cases showing unusual clinical presentations. Acta Neuropathol 2001;102:553-571.
45. Binetti G, Locascio JJ, Corkin S, et al. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol 2000;57:225-232.